Understanding the influences of particle properties of antigen-adjuvant complexes on immunity is crucial in designing highly active adjuvants for new-generation of vaccines. This paper briefly revisits the current opinions on the size-dependent immunity of various adjuvant particles and then comprehensively discusses a few immunity-determining processes that are affected by the antigen-adjuvant particle properties. These include particle size, surface charge, surface hydrophilicity/lipophilicity, and antigen-adjuvant binding strength. Based on current understandings, we hypothesize that a maximum immune response occurs at a certain antigen-adjuvant particle size. This hypothesis clearly explains the paradoxical opinions on the size-dependen...
Until recently, vaccines were largely comprised of whole cell killed and attenuated pathogens. Howev...
One of priority issues of the present-day healthcare system is development of new vaccines and impro...
Adjuvants are required to ensure the efficacy of subunit vaccines. Incorporating molecular immunop...
Particle based adjuvant showed promising signs on delivering antigen to immune cells and acting as s...
Particulate carrier systems are promising drug delivery vehicles for subunit vaccination as they c...
Adsorption of the antigen to an aluminum-containing adjuvant is considered an important aspect of va...
Nano- and micro-particulate carriers enable the site-specific delivery for controlled biological res...
The use of microparticles (MPs) as adjuvants has attracted increasing interest in vaccine delivery s...
Routine vaccination was initiated in the early 20th century and is now considered one of the most be...
Influenza is a major challenge to healthcare systems world-wide. While prophylactic vaccination is l...
Experience has shown that the initiation, quality, and magnitude of the immune response to a vaccine...
Despite the immense public health successes of immunization over the past century, effective vaccine...
Since the discovery of the first virus-like particle (VLP) derived from hepatitis B virus in 1980 (1...
The distribution of antigens in mono-valent and combination vaccines was studied by conjugating gree...
The mechanism by which vaccine adjuvants enhance immune responses has historically been considered t...
Until recently, vaccines were largely comprised of whole cell killed and attenuated pathogens. Howev...
One of priority issues of the present-day healthcare system is development of new vaccines and impro...
Adjuvants are required to ensure the efficacy of subunit vaccines. Incorporating molecular immunop...
Particle based adjuvant showed promising signs on delivering antigen to immune cells and acting as s...
Particulate carrier systems are promising drug delivery vehicles for subunit vaccination as they c...
Adsorption of the antigen to an aluminum-containing adjuvant is considered an important aspect of va...
Nano- and micro-particulate carriers enable the site-specific delivery for controlled biological res...
The use of microparticles (MPs) as adjuvants has attracted increasing interest in vaccine delivery s...
Routine vaccination was initiated in the early 20th century and is now considered one of the most be...
Influenza is a major challenge to healthcare systems world-wide. While prophylactic vaccination is l...
Experience has shown that the initiation, quality, and magnitude of the immune response to a vaccine...
Despite the immense public health successes of immunization over the past century, effective vaccine...
Since the discovery of the first virus-like particle (VLP) derived from hepatitis B virus in 1980 (1...
The distribution of antigens in mono-valent and combination vaccines was studied by conjugating gree...
The mechanism by which vaccine adjuvants enhance immune responses has historically been considered t...
Until recently, vaccines were largely comprised of whole cell killed and attenuated pathogens. Howev...
One of priority issues of the present-day healthcare system is development of new vaccines and impro...
Adjuvants are required to ensure the efficacy of subunit vaccines. Incorporating molecular immunop...